ALDH1A1 and breast carcinoma: Moreover, in vivo study in the ER-positive breast cancer model showed that estrone promotes tumor progression, inflammation response, and increases ALDH1 activity as a breast cancer stem cell marker that suggests a worse breast cancer prognosis [28].